Health care associated infections, antibiotic resistance and clinical outcome: A surveillance study from Sanandaj, Iran

Table 2 Prevalence of infections and crude mortality by age groups and isolated organisms n (%)

Age groups Bacteria	Neonatal (< 28 d)	Infantile (1-11 mo)	Childhood (1-17 yr)	Adults (18-59 yr)	Elderly (> 60 yr)	Total isolates	Crude mortality by bacteria
Escherichia coli	3 (20)1	0	5 (33.3)1	2 (13.3)1	5 (33.3)1	15 (19)2	3 (23.1)3
Klebsiella pneumoniae	10 (66.7)	0	1 (6.7)	4 (26.7)	0	15 (19)2	2 (15.4)
Acinetobacter baumannii	3 (60.0)	0	0	1 (20)	1 (20)	5 (5.6)2	1 (7.7)
Pseudomonas aeruginosa	0	1 (50)	1 (50)	0	0	2 (2.2)2	1 (7.7)
Pseudomonas oryzihabitans	0	0	0	1 (100)	0	1 (1.1)2	0
Serratia marcescens	2 (6.7)	6 (20)	11 (36.7)	7 (23.3)	4 (13.3)	30 (33.3)2	6 (46.1)
Enterobacter cloacae	0	0	2 (40)	1 (20)	2 (40)	5 (5.6)2	0
Stenotrophomonas maltophilia	0	0	0	1 (100)	0	1 (1.1)2	0
Klebsiella oxytoca	0	0	0	0	1 (100)	1 (1.1)2	0
Serratia odorifera	2 (66.7)	0	1 (33.3)	0	0	3 (3.3)2	0
Pseudomonas luteola	0	0	0	0	1 (100)	1 (1.1)2	0
Total Isolates in the age groups	20 (25)	7 (8.8)	21 (26.5)	17 (21.5)	14 (17.7)	79 (100)	-
Crude mortality by age	4 (30.8)3	0	2 (15.4)	4 (30.7)	3 (23.1)	-	13 (100)

¹Percent within each isolate;

²Percent within total isolates of a specific bacteria;

³Percent within total mortality.